FELLOW EYE CHANGES IN PATIENTS WITH NONISCHEMIC CENTRAL RETINAL VEIN OCCLUSION: Assessment of Perfused Foveal Microvascular Density and Identification of Nonperfused Capillaries

Purpose: Eyes fellow to nonischemic central retinal vein occlusion (CRVO) were examined for abnormalities, which might explain their increased risk for future occlusion, using adaptive optics scanning light ophthalmoscope fluorescein angiography. Methods: Adaptive optics scanning light ophthalmoscope fluorescein angiography foveal microvascular densities were calculated. Nonperfused capillaries adjacent to the foveal avascular zone were identified. Spectral domain optical coherence tomography, ultrawide field fluorescein angiographies, and microperimetry were also performed. Results: Ten fellow eyes of nine nonischemic CRVO and 1 nonischemic hemi-CRVO subjects and four affected eyes of three nonischemic CRVO and one nonischemic hemi-CRVO subjects were imaged. Ninety percent of fellow eyes and 100% of affected eyes demonstrated at least 1 nonperfused capillary compared with 31% of healthy eyes. Fellow eye microvascular density (35 ± 3.6 mm−1) was significantly higher than that of affected eyes (25 ± 5.2 mm−1) and significantly lower than that of healthy eyes (42 ± 4.2 mm−1). Compared with healthy controls, spectral domain optical coherence tomography thicknesses showed no significant difference, whereas microperimetry and 2/9 ultrawide field fluorescein angiography revealed abnormalities in fellow eyes. Conclusion: Fellow eye changes detectable on adaptive optics scanning light ophthalmoscope fluorescein angiography reflect subclinical pathology difficult to detect using conventional imaging technologies. These changes may help elucidate the pathogenesis of nonischemic CRVO and help identify eyes at increased risk of future occlusion.

[1]  G. Giuffrè,et al.  Central retinal vein occlusion in young people , 2004, Documenta Ophthalmologica.

[2]  P. Mitchell,et al.  Natural history of central retinal vein occlusion: an evidence-based systematic review. , 2010, Ophthalmology.

[3]  J. Altschmied,et al.  Redox balance in the aged endothelium , 2013, Zeitschrift für Gerontologie und Geriatrie.

[4]  David H Sliney,et al.  Maximum permissible exposures for ocular safety (ANSI 2000), with emphasis on ophthalmic devices. , 2007, Journal of the Optical Society of America. A, Optics, image science, and vision.

[5]  J. Jonas,et al.  PREVALENCE AND ASSOCIATIONS OF RETINAL VEIN OCCLUSIONS: The Central India Eye and Medical Study , 2013, Retina.

[6]  S. Taddei,et al.  Impact of inflammation on vascular disease in hypertension. , 2014, Maturitas.

[7]  A. Dubra,et al.  Reflective afocal broadband adaptive optics scanning ophthalmoscope , 2011, Biomedical optics express.

[8]  R. Klein,et al.  Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. , 2008, Investigative ophthalmology & visual science.

[9]  Alfredo Dubra,et al.  Assessment of perfused foveal microvascular density and identification of nonperfused capillaries in healthy and vasculopathic eyes. , 2014, Investigative ophthalmology & visual science.

[10]  Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. , 1997, Archives of ophthalmology.

[11]  P. Mitchell,et al.  Natural history of branch retinal vein occlusion: an evidence-based systematic review. , 2010, Ophthalmology.

[12]  K. Park,et al.  Retinal nerve fiber layer thickness is decreased in the fellow eyes of patients with unilateral retinal vein occlusion. , 2011, Ophthalmology.

[13]  Tien Yin Wong,et al.  The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. , 2010, Ophthalmology.

[14]  A. Alhusban,et al.  Diabetes exacerbates retinal oxidative stress, inflammation, and microvascular degeneration in spontaneously hypertensive rats , 2012, Molecular vision.

[15]  J. Jonas,et al.  The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study. , 2013, Ophthalmology.

[16]  Justis P. Ehlers,et al.  Retinal vein occlusion: beyond the acute event. , 2011, Survey of ophthalmology.

[17]  Po-Len Liu,et al.  Endothelial Progenitor Cell Dysfunction in Cardiovascular Diseases: Role of Reactive Oxygen Species and Inflammation , 2012, BioMed research international.

[18]  D. Atchison,et al.  The eye and visual optical instruments: Frontmatter , 1997 .

[19]  S. Reddy,et al.  Reactive oxygen species in inflammation and tissue injury. , 2014, Antioxidants & redox signaling.

[20]  I. McAllister Central retinal vein occlusion: a review , 2012, Clinical & experimental ophthalmology.

[21]  Ulrich Schraermeyer,et al.  A central role for inflammation in the pathogenesis of diabetic retinopathy , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  A. Papavassiliou,et al.  Inflammatory markers in hyperlipidemia: from experimental models to clinical practice. , 2011, Current pharmaceutical design.

[23]  E. Coban,et al.  The Association of Low-Grade Systemic Inflammation with Hypertensive Retinopathy , 2010, Clinical and experimental hypertension.

[24]  T. Hirose,et al.  Electroretinographic findings in fellow eyes of patients with central retinal vein occlusion. , 1989, Archives of ophthalmology.

[25]  M. Matsumura,et al.  Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy , 2007, Molecular vision.

[26]  J. Flammer,et al.  Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins , 2010, EPMA Journal.

[27]  D. Macdonald The ABCs of RVO: A review of retinal venous occlusion , 2014, Clinical & experimental optometry.

[28]  J. B. Lopes de Faria,et al.  Hypertension Increases Retinal Inflammation in Experimental Diabetes: A Possible Mechanism for Aggravation of Diabetic Retinopathy by Hypertension , 2007, Current eye research.

[29]  P. Koulen,et al.  NORMATIVE DATA SET IDENTIFYING PROPERTIES OF THE MACULA ACROSS AGE GROUPS: Integration of Visual Function and Retinal Structure With Microperimetry and Spectral-Domain Optical Coherence Tomography , 2011, Retina.

[30]  A. Dubra,et al.  In vivo imaging of human retinal microvasculature using adaptive optics scanning light ophthalmoscope fluorescein angiography , 2013, Biomedical optics express.

[31]  R. Gallego-Pinazo,et al.  Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma. , 2013, Current opinion in pharmacology.